Zdrowie i gospodarka · 27/07/2018

FDA Clears Metaxalone Tablets for Approval

The US Food and Drug Administration (FDA) has made a determination that metaxalone tablets, 640 milligrams, were not withdrawn from sale due to safety or effectiveness concerns, paving the way for potential approval of abbreviated new drug applications (ANDAs) for the medication.